carbamates has been researched along with Sandhoff Disease in 1 studies
Sandhoff Disease: An autosomal recessive neurodegenerative disorder characterized by an accumulation of G(M2) GANGLIOSIDE in neurons and other tissues. It is caused by mutation in the common beta subunit of HEXOSAMINIDASE A and HEXOSAMINIDASE B. Thus this disease is also known as the O variant since both hexosaminidase A and B are missing. Clinically, it is indistinguishable from TAY-SACHS DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marshall, J | 1 |
| Nietupski, JB | 1 |
| Park, H | 1 |
| Cao, J | 1 |
| Bangari, DS | 1 |
| Silvescu, C | 1 |
| Wilper, T | 1 |
| Randall, K | 1 |
| Tietz, D | 1 |
| Wang, B | 1 |
| Ying, X | 1 |
| Leonard, JP | 1 |
| Cheng, SH | 1 |
1 other study available for carbamates and Sandhoff Disease
| Article | Year |
|---|---|
Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity.
Topics: Animals; beta-Hexosaminidase beta Chain; Brain; Carbamates; Disease Models, Animal; Enzyme Inhibitor | 2019 |